Table 2.
All-cause healthcare resource utilization and costs (per patient per year)
| Resources and costs | Pre-index period (nmCRPC) | Post-index period (mCRPC) | P value |
|---|---|---|---|
| Healthcare resource | |||
| Total medical and pharmacy claims | 63.79 ± 31.45 | 119.95 ± 49.41 | < 0.0001 |
| Pharmacy claims | 31.12 ± 20.97 | 50.05 ± 26.39 | < 0.0001 |
| Inpatient admissions | 0.20 ± 0.36 | 1.35 ± 1.79 | < 0.0001 |
| Office visits | 11.69 ± 5.87 | 21.03 ± 10.28 | < 0.0001 |
| ED visits | 0.63 ± 1.55 | 1.56 ± 2.38 | < 0.0001 |
| Outpatient services | 20.14 ± 12.15 | 45.95 ± 28.03 | < 0.0001 |
| Total length of inpatient stay (in days) | 0.94 ± 2.58 | 6.80 ± 17.44 | < 0.0001 |
| Healthcare costs | |||
| Total medical and pharmacy | 35,102.55 ± 39,524.11 | 156,499.89 ± 105,581.14 | < 0.0001 |
| Pharmacy | 7942.49 ± 11,590.16 | 41,458.79 ± 38,327.74 | < 0.0001 |
| Inpatient admissions | 5288.90 ± 23,822.33 | 26,749.69 ± 62,366.92 | < 0.0001 |
| Office visits | 1341.07 ± 988.47 | 2978.89 ± 6442.89 | < 0.0001 |
| ED visits | 473.27 ± 1127.86 | 1490.45 ± 4717.63 | 0.0005 |
| Outpatient services | 20,056.82 ± 24,039.01 | 83,822.08 ± 88,066.36 | < 0.0001 |
Data are presented as mean ± standard deviation unless otherwise indicated. Costs are standardized to $US, year 2015 values
ED emergency department, mCRPC metastatic castration-resistant prostate cancer, nmCRPC nonmetastatic castration-resistant prostate cancer